Research Topics
| G M PetersonSummaryAffiliation: University of Tasmania Country: Australia Publications
| Collaborators
|
Detail Information
Publications
Home medicines reviews following acute coronary syndrome: study protocol for a randomized controlled trialDaniel D L Bernal
Unit for Medication Outcomes Research and Education UMORE, School of Pharmacy, University of Tasmania UTAS, Sandy Bay Campus, Tasmania 7001, Australia
Trials 13:30. 2012..We have made two minor adjustments to target the focus of the existing service including an acute coronary syndrome specific referral letter and a training package for the pharmacists providing the service...
A role for pharmacists in community-based post-discharge warfarin management: protocol for the 'the role of community pharmacy in post hospital management of patients initiated on warfarin' studyLeanne Stafford
Unit for Medication Outcomes Research and Education, School of Pharmacy, University of Tasmania, Hobart, Tasmania, Australia
BMC Health Serv Res 11:16. 2011..The current study aims to modify this previously trialled service model to implement and then evaluate a sustainable program to enable the smooth transition of patients taking warfarin from the hospital to community setting...
Engaging community pharmacists in the primary prevention of cardiovascular disease: protocol for the Pharmacist Assessment of Adherence, Risk and Treatment in Cardiovascular Disease (PAART CVD) pilot studyKevin P Mc Namara
Department of Pharmacy Practice, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Centre for Medicine Use and Safety, 381 Royal Parade, Parkville, VIC 3052, Australia
BMC Health Serv Res 10:264. 2010..It is therefore important to demonstrate the feasibility of multiple risk factor management by community pharmacists to ensure continued currency of their role...
Evaluation of a community pharmacy-based intervention for improving patient adherence to antihypertensives: a randomised controlled trialRosalind Lau
Centre for Medicine Use and Safety, Department of Pharmacy Practice, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, 381 Royal Parade, Parkville, VIC 3052, Australia
BMC Health Serv Res 10:34. 2010....
Pharmacist's attitudes towards dispensing errors: their causes and preventionG M Peterson
Tasmanian School of Pharmacy, Faculty of Health Science, University of Tasmania, Hobart, Australia
J Clin Pharm Ther 24:57-71. 1999..To assess the attitudes of pharmacists towards the issue of dispensing errors...
Selecting nonprescription analgesicsGregory M Peterson
Tasmanian School of Pharmacy, Faculty of Health Science, University of Tasmania, Hobart, Tasmania 7001, Australia
Am J Ther 12:67-79. 2005..Despite the possibility of hepatotoxicity in overdose, paracetamol represents a better all-round option for most patients requiring OTC analgesic therapy...
Valproate: a simple chemical with so much to offerG M Peterson
Unit for Medication Outcomes Research and Education, School of Pharmacy, University of Tasmania, Hobart, Australia
J Clin Pharm Ther 30:417-21. 2005
Cardiovascular risk screening program in Australian community pharmaciesGregory M Peterson
Unit for Medication Outcomes Research and Education, School of Pharmacy, University of Tasmania, Locked Bag 26, Hobart, TAS, 7001, Australia
Pharm World Sci 32:373-80. 2010....
Attitudes of Australian pharmacists towards practice-based researchG M Peterson
Unit for Medication Outcomes Research and Education, Tasmanian School of Pharmacy, University of Tasmania, Tasmania, Australia
J Clin Pharm Ther 34:397-405. 2009..This included the canvassing of perceived barriers and potential solutions to promote research activity in pharmacy practice...
Public perceptions of the role of Australian pharmacists in cardiovascular diseaseG M Peterson
Unit for Medication Outcomes Research and Education, School of Pharmacy, Faculty of Health Science, University of Tasmania, Tasmania, Australia
J Clin Pharm Ther 35:671-7. 2010..To assess the public's perception of pharmacists' involvement and role in cardiovascular disease prevention and management...
Harm minimization strategies: opinions of health professionals in rural and remote AustraliaG M Peterson
Unit for Medication Outcomes Research and Education, School of Pharmacy, University of Tasmania, Tasmania, Australia
J Clin Pharm Ther 32:497-504. 2007..This study was conducted to determine barriers to implementation, access to, and success of HM strategies, as seen by health professionals presently working in rural Australia...
Educational campaign to improve the prevention of postoperative venous thromboembolismG M Peterson
Tasmanian School of Pharmacy, Faculty of Health Science, University of Tasmania, Hobart, Australia
J Clin Pharm Ther 24:279-87. 1999..This project comprised a baseline assessment of the use of preventive measures within the Royal Hobart Hospital, followed by the implementation and evaluation of an educational program directed at hospital staff...
Violence in community pharmacy in Australia: incidence and implicationsGregory M Peterson
School of Pharmacy, University of Tasmania, Hobart, TAS, 7001, Australia
Int J Clin Pharm 33:264-72. 2011..To estimate the frequency, nature and impact of violent incidents in Australian community pharmacies...
Ipratropium treatment of acute airways diseaseGregory M Peterson
Tasmanian School of Pharmacy, Faculty of Health Science, University of Tasmania, Hobart, Australia
Ann Pharmacother 37:339-44. 2003..To examine the use of ipratropium bromide in adults with acute exacerbation of either asthma or chronic obstructive pulmonary disease (COPD) during admission and at discharge from 3 teaching hospitals...
Impact of pharmacist-conducted home visits on the outcomes of lipid-lowering drug therapyG M Peterson
School of Pharmacy, University of Tasmania, Hobart, Tasmania, Australia
J Clin Pharm Ther 29:23-30. 2004..To evaluate a pharmacist-conducted educational and monitoring programme, designed to promote dietary and lifestyle modification and compliance with lipid-lowering drug therapy, for patients with dyslipidaemia...
Lasofoxifene: selective estrogen receptor modulator for the prevention and treatment of postmenopausal osteoporosisGregory M Peterson
School of Pharmacy, University of Tasmania, Tasmania, Australia
Ann Pharmacother 45:499-509. 2011..To review literature evaluating the pharmacology, pharmacokinetics, clinical efficacy, and adverse effects of lasofoxifene (CP-336156), a selective estrogen receptor modulator (SERM) that is not approved for use in the US...
Improving the outcomes of anticoagulation in rural Australia: an evaluation of pharmacist-assisted monitoring of warfarin therapyS L Jackson
School of Pharmacy, University of Tasmania, Hobart, TAS, Australia
J Clin Pharm Ther 30:345-53. 2005..Further research needs to be conducted on the impact of community pharmacy-conducted INR monitoring on patient care and outcomes...
Improving the outcomes of anticoagulation: an evaluation of home follow-up of warfarin initiationS L Jackson
School of Pharmacy, University of Tasmania, Tasmania, Australia
J Intern Med 256:137-44. 2004..01). CONCLUSIONS: This programme improved the initiation of warfarin therapy and resulted in a significant decrease in haemorrhagic complications in the first 3 months of therapy...
Stroke risk assessment for atrial fibrillation: hospital-based stroke risk assessment and intervention programS L Jackson
Unit for Medication Outcomes Research and Education, School of Pharmacy, University of Tasmania, Hobart, Tasmania, Australia
J Clin Pharm Ther 36:71-9. 2011..The aim of this study was to implement and evaluate a system to improve the appropriate use of antithrombotics for stroke prevention in AF utilizing a clinical pharmacist as a stroke risk assessor...
Warfarin management after discharge from hospital: a qualitative analysisL Stafford
Unit for Medication Outcomes Research and Education UMORE, School of Pharmacy, University of Tasmania, Hobart, TAS, Australia
J Clin Pharm Ther 37:410-4. 2012....
Outcomes in the management of atrial fibrillation: clinical trial results can apply in practiceS L Jackson
Tasmanian School of Pharmacy, Faculty of Health Science, University of Tasmania, Hobart, Australia
Intern Med J 31:329-36. 2001..In clinical practice, warfarin confers a similar stroke risk reduction to that observed in trials, with an increase in incidence of only minor bleeding complications. Aspirin did not appear to reduce the risk of stroke...
A methodological framework for estimating the clinical and economic value of community pharmacists' clinical interventions using expert opinionA C Stafford
Unit for Medication Outcomes Research and Education, School of Pharmacy, University of Tasmania, Hobart, Tasmania, Australia
J Clin Pharm Ther 37:378-85. 2012..This paper aimed to describe the complexities involved in estimating the clinical and economic outcomes of CIs performed by community pharmacists when using expert opinion and suggest avenues for improvement...
Evaluation of repellent properties of volatile extracts from the Australian native plant Kunzea ambigua against Aedes aegypti (Diptera: Culcidae)J Thomas
School of Pharmacy, University of Tasmania, Private Bag 26, Hobart, 7001 TAS, Australia
J Med Entomol 46:1387-91. 2009..ambigua oil. Both K. ambigua oil and citronella were significantly less repellent than deet. The K. ambigua essential oil formulations should not be advocated for use as repellents in regions prone to mosquito-borne disease...
Point-of-care monitoring of anticoagulant therapy by rural community pharmacists: description of successful outcomesShane L Jackson
Tasmanian School of Pharmacy, University of Tasmania, Hobart, Tasmania 7001, Australia
Aust J Rural Health 12:197-200. 2004..Innovative service delivery models like these are needed to meet the needs of the increasing number of rural Australians requiring warfarin therapy...
Pharmacist-provided quantitative heel ultrasound screening for rural women at risk of osteoporosisMark Naunton
Faculty of Health Science, Tasmanian School of Pharmacy, University of Tasmania, Tasmania, Australia
Ann Pharmacother 40:38-44. 2006..CONCLUSIONS: Pharmacist-provided screening for osteoporosis in rural areas is a potentially useful method to identify women at risk for fracture and a convenient time point for discussion of preventive therapy...
Marketing of rural and remote pharmacy practice via the digital mediumG M Peterson
Unit for Medication Outcomes Research and Education, School of Pharmacy, University of Tasmania, Hobart, Australia
J Clin Pharm Ther 35:409-14. 2010..This DVD will complement current rural practical placements, which have been incorporated into the curriculum of Australian schools of pharmacy...
Data-mining of medication records to improve asthma managementBonnie J Bereznicki
Unit for Medication Outcomes Research and Education, School of Pharmacy, University of Tasmania, Hobart, TAS, Australia
Med J Aust 189:21-5. 2008..To use community pharmacy medication records to identify patients whose asthma may not be well managed and then implement and evaluate a multidisciplinary educational intervention to improve asthma management...
Pharmacist-initiated general practitioner referral of patients with suboptimal asthma managementBonnie J Bereznicki
Unit for Medication Outcomes Research and Education, School of Pharmacy, University of Tasmania, Tasmania, Australia
Pharm World Sci 30:869-75. 2008..Setting Community pharmacies throughout Tasmania, Australia...
New antithrombotics for atrial fibrillationLuke R E Bereznicki
Unit for Medication Outcomes Research and Education, School of Pharmacy, University of Tasmania, Hobart, Australia
Cardiovasc Ther 28:278-86. 2010..These new anticoagulants may well represent a new era in anticoagulation. However, they do possess their own limitations and will present new challenges for clinicians...
Training Australian pharmacists for participation in a collaborative, home-based post-discharge warfarin management serviceLeanne Stafford
Unit for Medication Outcomes Research and Education UMORE, School of Pharmacy, University of Tasmania, Private Bag 26, 7001, Hobart, Tasmania
Pharm World Sci 32:637-42. 2010..To describe the development, implementation and outcomes of an anticoagulation education program for pharmacists participating in a community-based post-discharge warfarin management service...
Plasma glutathione peroxidase by ELISA and relationship to selenium levelGlenn A Jacobson
School of Pharmacy, University of Tasmania, Private Bag 26, Hobart, Tasmania 7001, Australia
Clin Chim Acta 369:100-3. 2006..Many assays have investigated GPx activity but there are few reports of immunoreactive methods of GPx plasma determinations and their relationship with plasma selenium...
Drug-related problems identified in medication reviews by Australian pharmacistsAndrew C Stafford
Unit for Medication Outcomes Research and Education, School of Pharmacy, University of Tasmania, Private Bag 26, Hobart, TAS 7001, Australia
Pharm World Sci 31:216-23. 2009..The objective of this study was to examine the number and nature of the drug-related problems identified and investigate differences between each type of review...
Accuracy and clinical usefulness of the near-patient testing CoaguChek S international normalised ratio monitor in rural medical practiceShane L Jackson
School of Pharmacy, University of Tasmania, Hobart, Tasmania
Aust J Rural Health 12:137-42. 2004..CONCLUSIONS: The routine use of near-patient testing, with appropriate training and quality assurance programs, has the potential to increase the safety and efficacy of warfarin therapy in rural and remote communities...
Accuracy and clinical utility of the CoaguChek XS portable international normalised ratio monitor in a pilot study of warfarin home-monitoringLuke R Bereznicki
Unit for Medication Outcomes Research and Education, School of Pharmacy, University of Tasmania, Hobart, Australia
J Clin Pathol 60:311-4. 2007..To evaluate the accuracy of the CoaguChek XS international normalised ratio (INR) monitor compared with the laboratory method...
Vitamin B12 deficiency in Australian residential aged care facilitiesC Mirkazemi
Unit for Medication Outcomes Research and Education, School of Pharmacy, University of Tasmania, Hobart, Tasmania 7001, Australia
J Nutr Health Aging 16:277-80. 2012..To determine the prevalence of undiagnosed vitamin B12 deficiency among residential aged care facility residents in southern Tasmania, Australia, and to identify associated risk factors...
The risks of warfarin use in the elderlyLuke R Bereznicki
Unit for Medication Outcomes Research and Education, School of Pharmacy, University of Tasmania, Hobart, Tasmania, Australia
Expert Opin Drug Saf 5:417-31. 2006....
Thromboprophylaxis following hip and knee arthroplastyC Mirkazemi
School of Pharmacy, University of Tasmania, Hobart, Tasmania, Australia
Intern Med J 43:124-9. 2013..To determine local thromboprophylaxis prescribing practices following arthroplasty...
Development of an intelligent decision support system for medication reviewI K Bindoff
School of Computing, University of Tasmania, Tasmania, Australia
J Clin Pharm Ther 32:81-8. 2007..This intelligent system could directly support pharmacists and other health professionals providing medication reviews...
Toenail onychomycosis: an important global disease burdenJ Thomas
School of Pharmacy, University of Tasmania, Tasmania Department of Podiatry, Royal Hobart Hospital, Hobart, Tasmania, Australia
J Clin Pharm Ther 35:497-519. 2010..In patient populations such as diabetic individuals, where onychomycosis can provoke lower extremity complications, professional podiatry care of toenails and feet should be encouraged...
Undertreatment of congestive heart failure in an Australian settingP J Boyles
Tasmanian School of Pharmacy, University of Tasmania, Tasmania, Australia
J Clin Pharm Ther 29:15-22. 2004..The relatively low use of drugs shown to improve survival in heart failure is of concern and warrants educational intervention...
Randomised controlled trial of the treatment of pastern dermatitis with a formulation containing kunzea oilJ Thomas
School of Pharmacy, University of Tasmania, Hobart 7001, Tasmania, Australia
Vet Rec 164:619-23. 2009..The control formulation resulted in no significant change in the total area of the lesions, and the signs of pastern dermatitis resolved completely in only two of the 10 cases...
Selenium status in Southern TasmaniaG A Jacobson
School of Pharmacy, University of Tasmania, Hobart, Tasmania, Australia
Eur J Clin Nutr 61:1057-63. 2007..To assess the selenium status of Southern Tasmanians...
A community-based educational intervention to improve antithrombotic drug use in atrial fibrillationShane L Jackson
Tasmanian School of Pharmacy, University of Tasmania, Tasmania, Australia
Ann Pharmacother 38:1794-9. 2004..001). CONCLUSIONS: The educational program described here led to a significant increase in the prescribing of warfarin for stroke prevention in patients with AF...
An electronic prompt in dispensing software to promote clinical interventions by community pharmacists: a randomized controlled trialJames F Reeve
Unit for Medication Outcomes Research and Education, School of Pharmacy, University of Tasmania, Australia
Br J Clin Pharmacol 65:377-85. 2008..A markedly increased rate of recording and performing the targeted clinical intervention was found. The effect of the prompt reduces markedly once the prompt is deactivated...
Psycholeptic use in aged care homes in Tasmania, AustraliaJ L Westbury
Unit for Medication Outcomes Research and Education UMORE, School of Pharmacy, University of Tasmania, Hobart, 7001 Tasmania, Australia
J Clin Pharm Ther 35:189-93. 2010..The aim of this study was to examine the current pattern of psycholeptic use in Tasmanian aged care homes and compare this data with other Australasian research...
Accuracy, reproducibility and clinical utility of the CoaguChek S portable international normalized ratio monitor in an outpatient anticoagulation clinicS L Jackson
School of Pharmacy, University of Tasmania, Tasmania, Australia
Clin Lab Haematol 26:49-55. 2004..The CoaguChek S displayed good correlation with laboratory determination of INR and compared relatively well with expanded and narrow clinical agreement criteria...
Case-controlled review of Clostridium difficile-associated diarrhoea in southern TasmaniaH A Halim
Tasmanian School of Pharmacy, Faculty of Medicine and Pharmacy, University of Tasmania, Australia
J Clin Pharm Ther 22:391-7. 1997..Severely ill patients with compromised immune function are particularly susceptible, with antibiotic use being a major risk factor. Prompt diagnosis and initiation of treatment are important factors in the improvement of prognosis...
Multifaceted educational program increases prescribing of preventive medication for corticosteroid induced osteoporosisMark Naunton
Tasmanian School of Pharmacy and Menzies Research Institute, Faculty of Health Science, University of Tasmania, Tasmania, Australia
J Rheumatol 31:550-6. 2004..CONCLUSION: A multifaceted education program, incorporating academic detailing of general practitioners and community pharmacists, increased the use of osteoporosis prevention strategies in longterm oral corticosteroid users...
Comment: increased sensitivity to warfarin after heart valve replacementLuke R Bereznicki
Ann Pharmacother 40:1476-7. 2006
Clopidogrel-aspirin combination for atrial fibrillation: CLAAF is not CLEARShane L Jackson
Am Heart J 149:e3; author reply e4. 2005
Randomized trial of warfarin nomogramsGregory M Peterson
Ann Intern Med 140:488; author reply 491-2. 2004
Addressing information needs in the management of osteoporosisMark Naunton
Osteoporos Int 15:505; author reply 506. 2004
Risk factors...but only after excluding high-risk subjectsGregory M Peterson
Pharmacoepidemiol Drug Saf 13:253; author reply 255-6. 2004
Practical utility of case-management telephone intervention in heart failure?Gregory M Peterson
Arch Intern Med 162:2142-3; author reply 2143. 2002
Comments on Glintborg et al.'s drug-drug interactions study (EJCP 2005; 61: 675-681)Mark Naunton
Eur J Clin Pharmacol 62:159-60. 2006
Over-the-counter antifungal drug misuse associated with patient-diagnosed vulvovaginal candidiasisGregory M Peterson
Obstet Gynecol 100:381; author reply 381-2. 2002
The direct thrombin inhibitor melagatran/ximelagatranLuke R Bereznicki
Med J Aust 182:254-5. 2005
